NIH-funded research R01 grant

Understanding how a specific enzyme affects mutations in breast cancer

Official title: Regulation of APOBEC3 cytidine deaminase-induced mutation during cancerdevelopment

Funded at University of Vermont & St Agric College · NIH-11005220 · Data updated 2026-11-12

This study is looking at how a specific enzyme called APOBEC3A might cause changes in breast cancer cells and how understanding this could help find new ways to treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startFebruary 6, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$472,605
NIH project number5R01CA269784-04
Project IDNIH-11005220 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with breast cancer, particularly those with mutations linked to the APOBEC signature.

Less likely to help

Patients with cancers unrelated to the APOBEC mutation signature may not benefit from this research.

What this research studies

This research investigates the role of the APOBEC3A enzyme in causing mutations in breast cancer cells. It aims to understand how this enzyme is regulated and how its activity contributes to cancer development. The study will explore the mechanisms that lead to increased expression of APOBEC3A in cancer and how this affects DNA repair processes. By identifying the factors that control this enzyme, the research seeks to uncover potential targets for therapeutic intervention.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating breast cancer by targeting the mechanisms of mutation caused by APOBEC3A.

How similar studies have gone: Other research has shown promising results in understanding the role of APOBEC enzymes in cancer, indicating that this approach has potential for significant findings.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Roberts, Steven a — University of Vermont & St Agric College
  • Study coordinator: Roberts, Steven a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.